天康生物：10月29日召开董事会会议

Group 1 - The company TianKang Biological (SZ 002100) held its 28th temporary board meeting on October 29, 2025, via communication voting to review the "2025 Q3 Report" and other documents [1] - For the first half of 2025, the revenue composition of TianKang Biological was as follows: pig farming accounted for 32.2%, feed accounted for 27.51%, agricultural product processing accounted for 16.37%, corn storage industry accounted for 14.75%, and veterinary medicine accounted for 5.44% [1] - As of the report date, the market capitalization of TianKang Biological was 10.6 billion yuan [1] Group 2 - The A-share market has surpassed 4000 points, marking a significant resurgence after a decade of stagnation, with technology leading the market transformation and a new "slow bull" pattern emerging [1]